Potential Catalysts and Strategic Focus: Analyzing Alto Neuroscience's Upcoming Trials and Precision Psychiatry Approach

TipRanksNov 14 15:36

Alto Neuroscience Strengthens Financial Position Amid Increased R&D

TipRanksNov 14 12:44

Alto Neuroscience Analyst Ratings

BenzingaNov 13 23:18 · Ratings

Stifel Maintains Alto Neuroscience(ANRO.US) With Buy Rating, Cuts Target Price to $10

Futu NewsNov 13 21:31 · Ratings

Express News | Alto Neuroscience Inc : Stifel Cuts Target Price to $10 From $32

BreakingsNov 13 21:22

TD Cowen Maintains Alto Neuroscience(ANRO.US) With Buy Rating

Futu NewsNov 13 19:31 · Ratings